- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Neuroblastoma
- Meeting Date: March 2025
- Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) March 2025 PBAC Meeting - (Word)
Eflornithine – March 2025
Eflornithine; Tablet 192 mg (as hydrochloride); Ifinwil®
Last updated
12 March 2025